Skyclarys announced its international expansion into Brazil and the U.K. on July 22, 2025.
1 report, 1 independent
Updated Jul 22
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Skyclarys announced its international expansion into Brazil and the U.K. on July 22, 2025.
Who's involved
What this event is mainly aboutKeep exploring
Part of
Major pharmaceutical companies including Sanofi, Regeneron, Roche, Eli Lilly, Biogen, and Gilead are maintaining alliances and competing across key therapeutic areas like ophthalmology, immunology, and oncology.Also in this story
- Biogen enhances patient outcomes through key drugs and therapies, while NIH studies reveal global incidence of ALS and CDC projects rising patient numbers in the U.S.
- Sooin was appointed Chief Business and Strategy Officer at Galapagos, which also announced a partnership with Gilead.
- Collaboration agreements for oncology candidates were signed between several major pharmaceutical companies.
- TMO expanded a strategic partnership with Sanofi on August 28, 2025.
The entities involved
-
Biogen
American multinational biotechnology company
Nothing else this week.
Coverage
Newest first; wire copies grouped- Insider MonkeyBiogen Inc. (BIIB) Partners with Stoke Therapeutics to Tackle Dravet Syndrome We recently published 10 Most Undervalued Pharma Stocks To Buy Now. Biogen Inc. stands sixth on our list among the most u